Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03647358 · ClinicalTrials.gov registry record · Phase 1
Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma
A Phase 1 study of Thyroid Carcinoma and Metastatic Thyroid Carcinoma, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT03647358 is a Phase 1 study of Thyroid Carcinoma and Metastatic Thyroid Carcinoma that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03647358, a Phase 1 study of Thyroid Carcinoma and Metastatic Thyroid Carcinoma, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate a new diagnostic imaging test, positron emission tomography (PET), with a different radioactive form of iodine called iodine-124. This form is able to accurately measure the amount of radioactive iodine uptake in the cancer. If the new test determines sufficient radioiodine uptake in the cancer, treatment will continue as usual. However, if the new test shows only low radioiodine uptake, a decision may be made that the benefit from radioiodine therapy is insufficient and that another form of therapy is preferred.
Conditions Studied
Interventions
- DEVICE PET/CT Scan
- DRUG Iodine-124
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2018-08-21 |
| Est. Completion | 2027-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03647358
The ClinicalTrials.gov registry entry for NCT03647358 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Thyroid Carcinoma appearing as the primary indexed condition, and to 2 interventions - of which PET/CT Scan is the first listed.
NCT03647358 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03647358 about?
NCT03647358 is a clinical study titled "Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma". The purpose of this study is to evaluate a new diagnostic imaging test, positron emission tomography (PET), with a different radioactive form of iodine called iodine-124. This form is able to accurately measure the amount of radioactive iodine uptake in the cancer. If the new test determines suffici...
What is the current status of trial NCT03647358?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2018-08-21. Estimated completion is 2027-08.
What conditions does trial NCT03647358 study?
This clinical trial studies the following conditions: Thyroid Carcinoma, Metastatic Thyroid Carcinoma.
What interventions are being tested in trial NCT03647358?
The interventions under investigation include: PET/CT Scan (DEVICE), Iodine-124 (DRUG).
Who is sponsoring clinical trial NCT03647358?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03647358 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thyroid Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.